• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

口腔白斑恶变为恶性肿瘤:近 5 年的系统回顾和荟萃分析。

Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.

机构信息

Oral and Maxillofacial Medicine & Pathology Unit, Department of Stomatology II, Faculty of Medicine and Nursery, University of the Basque Country/EHU, Lejona, Spain.

Faculty of Dental, Oral & Craniofacial Sciences, King's College London and WHO Collaborating Centre for Oral Cancer, London, UK.

出版信息

Oral Dis. 2021 Nov;27(8):1881-1895. doi: 10.1111/odi.13810. Epub 2021 Apr 1.

DOI:10.1111/odi.13810
PMID:33606345
Abstract

OBJECTIVE

Oral leukoplakia (OL) is the most frequently encountered oral potentially malignant disorder. The aims of this systematic review are to estimate the overall malignant transformation of OL and to assess the risk factors associated with malignant transformation of OL published in the last 5 years (2015-2020).

MATERIALS AND METHODS

We performed a bibliographic search in PubMed, Scopus, Web of Science, Embase, and Cochrane databases with keywords "oral leukoplakia", "oral cancer", "oral carcinoma" and "oral squamous cell carcinoma". Meta-analysis was conducted using a random-effects model.

RESULTS

Twenty-four studies were selected, that reported a total of 16,604 patients. Malignant transformation proportion varied between 1.1% and 40.8%. Female gender, non-homogeneous clinical type, and presence of epithelial dysplasia were significantly related to MT. Other risk factors previously suggested did not show significant results.

CONCLUSIONS

The pooled proportion of malignant transformation MT was 9.8% (95% CI: 7.9-11.7). It is necessary to continue to conduct well-designed prospective clinicopathological studies on OL, using a uniform definition for OL to reduce the risk of bias for evaluating various factors associated with the MT.

摘要

目的

口腔白斑(OL)是最常见的口腔潜在恶性疾病。本系统评价的目的是评估 OL 整体恶变的概率,并评估过去 5 年(2015-2020 年)发表的与 OL 恶变相关的风险因素。

材料与方法

我们使用关键词“口腔白斑”、“口腔癌”、“口腔癌”和“口腔鳞状细胞癌”在 PubMed、Scopus、Web of Science、Embase 和 Cochrane 数据库中进行了文献检索。使用随机效应模型进行荟萃分析。

结果

共纳入 24 项研究,总计 16604 例患者。恶变比例在 1.1%至 40.8%之间。女性、非均质临床类型和上皮异型增生与 MT 显著相关。其他先前提示的风险因素未显示出显著结果。

结论

MT 的恶变总比例为 9.8%(95%CI:7.9-11.7)。有必要继续对 OL 进行设计良好的前瞻性临床病理研究,使用 OL 的统一定义,以降低评估与 MT 相关的各种因素时的偏倚风险。

相似文献

1
Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years.口腔白斑恶变为恶性肿瘤:近 5 年的系统回顾和荟萃分析。
Oral Dis. 2021 Nov;27(8):1881-1895. doi: 10.1111/odi.13810. Epub 2021 Apr 1.
2
Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: A systematic review.组织生物标志物预测诊断为口腔白斑病患者口腔癌风险:系统评价。
Oral Dis. 2021 Nov;27(8):1977-1992. doi: 10.1111/odi.13747. Epub 2021 Feb 2.
3
Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder.口腔红斑作为一种口腔潜在恶性疾病的重要更新、系统评价和荟萃分析。
J Oral Pathol Med. 2022 Aug;51(7):585-593. doi: 10.1111/jop.13304. Epub 2022 May 12.
4
Binary and WHO dysplasia grading systems for the prediction of malignant transformation of oral leukoplakia and erythroplakia: a systematic review and meta-analysis.用于预测口腔白斑和红斑恶变的二元分级系统和世界卫生组织发育异常分级系统:一项系统评价和荟萃分析
Clin Oral Investig. 2021 Jul;25(7):4329-4340. doi: 10.1007/s00784-021-04008-1. Epub 2021 May 29.
5
Interventions for treating oral leukoplakia.治疗口腔白斑的干预措施。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001829. doi: 10.1002/14651858.CD001829.pub3.
6
Intervention efficacy and malignant transformation to oral cancer among patients with leukoplakia (Review).白斑患者的干预疗效及口腔癌的恶变(综述)
Oncol Rep. 2003 Nov-Dec;10(6):1683-92.
7
Interventions for treating oral leukoplakia.治疗口腔白斑的干预措施。
Cochrane Database Syst Rev. 2004(3):CD001829. doi: 10.1002/14651858.CD001829.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块型银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2022 May 23;5(5):CD011535. doi: 10.1002/14651858.CD011535.pub5.
9
Recombinant Human Adenovirus- Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review.重组人腺病毒治疗口腔白斑病和口腔鳞状细胞癌的系统评价。
Medicina (Kaunas). 2021 May 1;57(5):438. doi: 10.3390/medicina57050438.
10
Interventions for central serous chorioretinopathy: a network meta-analysis.中心性浆液性脉络膜视网膜病变的干预措施:一项网状Meta分析
Cochrane Database Syst Rev. 2025 Jun 16;6(6):CD011841. doi: 10.1002/14651858.CD011841.pub3.

引用本文的文献

1
Lipid metabolites as biomarkers and therapeutic targets in oral squamous cell carcinoma.脂质代谢产物作为口腔鳞状细胞癌的生物标志物和治疗靶点
BMC Oral Health. 2025 Aug 31;25(1):1390. doi: 10.1186/s12903-025-06700-0.
2
Retinoic Acid Profiles in Proliferative Verrucous Versus Homogeneous Leukoplakia: A Preliminary Nested Case-Control Study.增殖性疣状白斑与均质型白斑的维甲酸谱:一项初步巢式病例对照研究。
Biomedicines. 2025 Aug 2;13(8):1881. doi: 10.3390/biomedicines13081881.
3
Simulation Modeling of Oral Cancer Development with Risk Stratification: How Potential Screening Programs Can Be Evaluated.
口腔癌发展的风险分层模拟建模:如何评估潜在的筛查项目。
MDM Policy Pract. 2025 Aug 19;10(2):23814683251353226. doi: 10.1177/23814683251353226. eCollection 2025 Jul-Dec.
4
Next-generation AI framework for comprehensive oral leukoplakia evaluation and management.用于全面口腔白斑评估与管理的下一代人工智能框架。
NPJ Digit Med. 2025 Aug 10;8(1):513. doi: 10.1038/s41746-025-01885-8.
5
Correlation of Newly Added Dysplastic Features in the Latest WHO Diagnostic Criteria of Oral Epithelial Dysplasia with Malignant Transformation and Recurrence.世界卫生组织口腔上皮发育异常最新诊断标准中新增发育异常特征与恶性转化及复发的相关性
Head Neck Pathol. 2025 Aug 7;19(1):98. doi: 10.1007/s12105-025-01835-6.
6
SOX11 and GLIS2: Novel Biomarkers for Understanding the Progression of Oral Leukoplakia.SOX11和GLIS2:用于理解口腔白斑进展的新型生物标志物。
Int Dent J. 2025 Jun 20;75(4):100872. doi: 10.1016/j.identj.2025.100872.
7
[Progress in clinicopathological diagnosis of oral potentially malignant disorders].[口腔潜在恶性疾病的临床病理诊断进展]
Hua Xi Kou Qiang Yi Xue Za Zhi. 2025 Jun 1;43(3):314-324. doi: 10.7518/hxkq.2025.2024427.
8
NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia.核因子E2相关因子2(NRF2)调节WNT信号通路以增强口腔白斑对光动力疗法的抗性。
EMBO Mol Med. 2025 Jun 10. doi: 10.1038/s44321-025-00256-w.
9
Comparative analysis of oral microbiome in saliva samples of oral leukoplakia, proliferative leukoplakia and oral squamous cell carcinoma.口腔白斑、增殖性白斑和口腔鳞状细胞癌唾液样本中口腔微生物群的比较分析。
Front Oral Health. 2025 May 14;6:1600090. doi: 10.3389/froh.2025.1600090. eCollection 2025.
10
Sulfasalazine combined with anti-IL-1β mAb induces ferroptosis and immune modulation in oral squamous cell carcinoma.柳氮磺胺吡啶联合抗IL-1β单克隆抗体可诱导口腔鳞状细胞癌发生铁死亡并调节免疫。
Cell Mol Life Sci. 2025 May 28;82(1):216. doi: 10.1007/s00018-025-05742-5.